Compensation & Benefits Officer at Legend Biotech

Ghent, Flanders, Belgium

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

Bachelor’s or Master’s degree in HR, Economics, or equivalent through experience
Minimum 2 years of experience in Compensation & Benefits or Payroll
Fluent in Dutch and English
Familiarity with HR systems like Protime, eBlox, and Workday is a plus
Solid understanding of Belgian C&B practices and legal frameworks
Analytical mindset with strong attention to detail
Proficient in Excel with an ability to manage and analyze data
Clear and confident communicator—able to simplify complex topics
Discreet, reliable, and service-oriented
Collaborative and proactive team player

Responsibilities

Manage the administration of fringe benefits such as group insurance, hospitalization insurance, mobility solutions, etc
Assist in conducting salary benchmarks and market comparisons
Support the development and execution of compensation strategies and budget simulations
Support various benefits programs such as the bike lease program, warrants, flex income plan, mobility budget,... and become the first point of contact regarding all operational questions
Assist in the yearly salary review and bonus & merit process
Monitor changes in social legislation and translate them into HR practices related to compensation & benefits
Collaborate with payroll to ensure accurate salary processing
Participate in various projects related to performance-based rewards, job classification,
Report to the Compensation & Benefits Lead and collaborate closely with the Head of Payroll, Compensation & Benefits EU and the payroll team

Skills

Benefits Administration

Salary Benchmarking

Compensation Analysis

Payroll Coordination

Market Comparisons

Bonus Processing

HR Legislation Monitoring

Job Classification

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free